HALSEY DRUG CO INC/NEW
4, 1999-08-10
PHARMACEUTICAL PREPARATIONS
Previous: HALSEY DRUG CO INC/NEW, 4, 1999-08-10
Next: HALSEY DRUG CO INC/NEW, 4, 1999-08-10



<PAGE>   1
                                              ----------------------------------
                                                          OMB APPROVAL
                                              ----------------------------------
                                              OMB Number 3235-0287
                                              Expires: February 1, 2001
                                              Estimated average burden
                                              hours per response ......0.5 hours
                                              ----------------------------------

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                  STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
       Section 17(a) of the Public Utility Holding Company Act of 1935 or
               Section 30(f) of the Investment Company Act of 1940

FORM 4
[_]  Check this box if no longer  subject to Section 16. Form 4 or Form 5
     obligations may continue. See Instruction 1(b).

________________________________________________________________________________
1.   Name and Address of Reporting Person*

CLEMENS                            PETER                    A.
- --------------------------------------------------------------------------------
   (Last)                           (First)             (Middle)

     c/o Halsey Drug Co.      695 N. Perryville Rd. Bldg. 2
- --------------------------------------------------------------------------------
                                    (Street)

Rockford                           Illinois              61107
- --------------------------------------------------------------------------------
   (City)                           (State)              (Zip)


________________________________________________________________________________
2.   Issuer Name and Ticker or Trading Symbol

                          HALSEY DRUG CO., INC. (HDG)

________________________________________________________________________________
3.   IRS or Social Security Number of Reporting Person (Voluntary)



________________________________________________________________________________
4.   Statement for Month/Year

                                      7/99

________________________________________________________________________________
5.   If Amendment, Date of Original (Month/Year)


________________________________________________________________________________
6.   Relationship of Reporting Person to Issuer
     (Check all applicable)

     [X]  Director                             [_]  10% Owner
     [X]  Officer (give title below)           [_]  Other (specify below)

                   Vice President and Chief Financial Officer
________________________________________________________________________________


________________________________________________________________________________
           Table I -- Non-Derivative Securities Acquired, Disposed of,
                             or Beneficially Owned
________________________________________________________________________________
<TABLE>
<CAPTION>
                                                                                                                6.
                                                                 4.                              5.             Owner-
                                                                 Securities Acquired (A) or      Amount of      ship
                                                    3.           Disposed of (D)                 Securities     Form:     7.
                                      2.            Transaction  (Instr. 3, 4 and 5)             Beneficially   Direct    Nature of
                                      Transaction   Code         ------------------------------- Owned at End   (D) or    Indirect
1.                                    Date          (Instr. 8)                   (A)             of Month       Indirect  Beneficial
Title of Security                     (Month/       ------------     Amount      or     Price    (Instr. 3      (I)       Ownership
(Instr. 3)                             Day/Year)     Code     V                  (D)             and 4)         (Instr.4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                                   <C>            <C>      <C>    <C>         <C>    <C>      <C>            <C>       <C>

Common Stock                          10/1/98        A*                842       A*     $1.8406                 D
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock                           1/1/99        A*              1,333       A*     $1.1625                 D
- ------------------------------------------------------------------------------------------------------------------------------------
                                                                                                  2,175
- ------------------------------------------------------------------------------------------------------------------------------------

</TABLE>

Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
*See Footnote (2) to Table II

                                                                          (Over)
<PAGE>   2
FORM 4 (continued)

Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
         (e.g., puts, calls, warrants, options, convertible securities)

________________________________________________________________________________
<TABLE>
<CAPTION>
                                                                                                                    10.
                                                                                                          9.        Owner-
                                                                                                          Number    ship
                                                                                                          of        Form
                    2.                                                                                    Deriv-    of
                    Conver-                    5.                              7.                         ative     Deriv-   11.
                    sion                       Number of                       Title and Amount           Secur-    ative    Nature
                    or                         Derivative    6.                of Underlying     8.       ities     Secur-   of
                    Exer-             4.       Securities    Date              Securities        Price    Bene-     ity:     In-
                    cise     3.       Trans-   Acquired (A)  Exercisable and   (Instr. 3 and 4)  of       ficially  Direct   direct
                    Price    Trans-   action   or Disposed   Expiration Date   ----------------  Deriv-   Owned     (D) or   Bene-
1.                  of       action   Code     of(D)         (Month/Day/Year)            Amount  ative    at End    In-      ficial
Title of            Deriv-   Date     (Instr.  (Instr. 3,    ----------------            or      Secur-   of        direct   Owner-
Derivative          ative    (Month/  8)       4 and 5)      Date     Expira-            Number  ity      Month     (I)      ship
Security            Secur-   Day/     ------   ------------  Exer-    tion               of      (Instr.  (Instr.   (Instr.  (Instr.
(Instr. 3)          ity      Year)    Code V    (A)   (D)    cisable  Date     Title     Shares  5)       4)        4)       4)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                 <C>      <C>      <C>  <C>  <C>   <C>    <C>      <C>      <C>       <C>     <C>      <C>       <C>      <C>
5% Convertible
Senior Secured                                                                 Common
Debentures          $1.404   3/10/98   A         (1)         3/10/98  3/15/03  Stock      71,225            71,225     D
- ------------------------------------------------------------------------------------------------------------------------------------
                                                                               Common
Warrants            $1.404   3/10/98   A         (1)         3/10/98  3/15/05  Stock      10,101            10,101     D
- ------------------------------------------------------------------------------------------------------------------------------------
                                                                               Common
Warrants            $2.279   3/10/98   A         (1)         3/10/98  3/15/05  Stock      10,101            10,101     D
- ------------------------------------------------------------------------------------------------------------------------------------
5% Convertible
Senior Secured                                                                 Common
Debentures          $1.404   6/12/98   A4        (2)         6/12/98  3/15/03  Stock      17,121            17,121     D
- ------------------------------------------------------------------------------------------------------------------------------------
                                                                               Common
Warrants            $1.404   6/12/98   A4        (2)         6/12/98  3/15/05  Stock       2,428             2,428     D
- ------------------------------------------------------------------------------------------------------------------------------------
                                                                               Common
Warrants            $2.279   6/12/98   A4        (2)         6/12/98  3/15/05  Stock       2,428             2,428     D
- ------------------------------------------------------------------------------------------------------------------------------------
Non-qualified                                                                  Common
Stock Options       $2.375   2/19/98   A4                      (3)    2/19/08  Stock     300,000           300,000     D
- ------------------------------------------------------------------------------------------------------------------------------------
5% Convertible
Senior Secured                                                                 Common
Debentures          $1.1312  4/1/99    A         (2)         4/1/99   3/15/03  Stock       1,370             1,370     D
- ------------------------------------------------------------------------------------------------------------------------------------
Non-qualified                                                                  Common
Stock Options       $1.125   4/12/99   A         (4)         3/8/00   3/8/09   Stock     100,000           100,000     D
- ------------------------------------------------------------------------------------------------------------------------------------
5% Convertible
Senior Secured                                                                 Common
Debentures          $2.4250  7/1/99    A         (2)         7/1/99   3/15/03  Stock         647               647     D
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

Explanation of Responses:

         (1) Purchased in connection with a private offering on March 10, 1998
consisting of a Convertible Debenture convertible at any time and Stock Purchase
Warrants (10,101 shares of which are presently exercisable at $1.404 per share
and 10,101 shares of which are presently exercisable at $2.279 per share).

         (2) Acquired pursuant to an option exercise in June 1998, consisting
of: (i) a Convertible Debenture, convertible at any time; (ii) Warrants to
purchase shares of common stock (2,428 shares of which are presently exercisable
at $1.404 per share and 2,428 shares of which are presently exercisable at
$2.279 per share); and (iii) certain interest payments payable quarterly which
are paid in the form of shares of common stock of the Issuer (See Table I).

         (3) Options vest quarterly, with 25,000 options vesting every quarter
effective May 1, 1998.

         (4) Options vest 25% annually, with 25,000 options vesting every March
8, beginning March 8, 2000.

                      /s/ Peter A. Clemens                  August  9 , 1999
                    --------------------------------     ---------------------
                    NAME: PETER A. CLEMENS                          DATE
                    SIGNATURE OF REPORTING PERSON

INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACTS CONSTITUTE FEDERAL CRIMINAL
VIOLATIONS.

See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

NOTE: FILE THREE COPIES OF THIS FORM, ONE OF WHICH MUST BE MANUALLY SIGNED. IF
SPACED PROVIDED IS INSUFFICIENT, SEE INSTRUCTION 6 FOR PROCEDURE.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission